SCHEMBL18613729

SCHEMBL18613729

OCc1cnc(Br)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27772771 0.84 — —
SCHEMBL216691 0.76 — —
SCHEMBL27772928 0.74 — —
SCHEMBL13187443 0.73 — —
SCHEMBL11481120 0.71 — —
SCHEMBL6851114 0.71 — —
SCHEMBL14012154 0.70 TSHR (0.38) —
Hydrochloric Acid SCHEMBL3583087 0.70 — —
SCHEMBL6986100 0.68 BRS3 (0.46) —
SCHEMBL8124411 0.68 HRH3 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3347018-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASES Dana-Farber Cancer Institute, Inc. (US) 2018-07-18 — — EP disclosed
WO-2017044858-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASES DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-03-16 — — WO disclosed
Send feedback